SelfDecode uses the only scientifically validated genetic prediction technology for consumers. Read more
You stretch. You foam roll. You ice. You rest between workouts. Your friends recover in days; you’re still sore a week later. Normal bloodwork comes back fine. Your doctor says it’s just aging or overtraining. But the truth is, your muscles aren’t recovering the way they should, and nobody’s looked at the actual mechanism: the genes controlling how your nervous system perceives and processes pain.
Written by the SelfDecode Research Team
✔️ Reviewed by a licensed physician
Chronic muscle soreness that doesn’t respond to rest, stretching, or standard recovery protocols usually isn’t a muscle problem at all. It’s a pain signaling problem. Your brain and nervous system have their own system for managing pain, and it runs on neurotransmitters like dopamine, serotonin, endogenous opioids, and endocannabinoids. When the genes controlling these systems have specific variants, your pain threshold drops, your recovery feels slower, and soreness lingers for weeks. Standard blood tests will never catch this because pain is a genetic trait encoded in your DNA, not a deficiency measurable in your bloodstream.
Six genes control how aggressively your nervous system signals pain and how effectively your endogenous pain-relief system works. If you carry variants in even one of them, your soreness can persist long after the tissue damage has healed. The intervention isn’t more stretching. It’s addressing the specific neurotransmitter imbalance your genes created.
Below, we’ll show you each gene, what your variant does, and the specific interventions that work for that particular pain pathway. Most people with chronic muscle soreness carry variants in at least two of these genes. That’s why a one-size-fits-all recovery approach never works.
Your muscles are actually healing fine. The problem is your nervous system is stuck in a heightened pain signal state. Pain perception is not a weakness or a sign you’re fragile. It’s a genetically determined trait. Some people’s brains are wired to amplify pain signals and dampen the endogenous pain-relief pathways. That wiring is set in your DNA. You can’t willpower your way out of a genetic pain amplification system, and rest alone won’t fix it because the issue isn’t tissue damage. It’s signal processing.
You finish a workout feeling fine. By the next day, the soreness is intense. By day three, normal people are recovered. You’re still sore. By day five, you’re frustrated because everyone else has moved on and you’re still in recovery mode. You double down on stretching and ice thinking you’re not recovering hard enough. You’re actually making it worse because you’re treating this like a tissue problem when it’s a neurotransmitter problem. The soreness isn’t telling you to rest harder. It’s telling you your pain modulation genes need support.
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Already have 23andMe or AncestryDNA data? Get your report without a new kit — upload your file today.
These genes control three critical pain pathways: how your nervous system generates pain signals, how effectively your brain’s natural pain-relief systems work, and how quickly you can dampen the pain signal once it starts. Most people with chronic muscle soreness carry variants in at least two of these.
COMT is an enzyme that breaks down catecholamines, the neurotransmitters your brain uses to modulate pain. When COMT is working normally, it keeps these pain-modulating chemicals at the right level. Too slow a clearance, and pain signals amplify. Too fast, and your pain relief system doesn’t work well either.
The Val158Met variant is extremely common. Roughly 25% of people of European ancestry are homozygous slow, meaning both copies of their COMT gene are the slow version. When you carry the slow variant, your nervous system takes much longer to clear dopamine and norepinephrine, which amplifies pain signaling in the central nervous system and leaves you hypersensitive to soreness.
What this feels like: Your muscles stay sore longer than they should. A workout that causes mild soreness in fast COMT people can leave you uncomfortable for a week. You’re not weaker or less fit. Your pain modulation system is just turned up louder.
People with slow COMT variants often respond well to magnesium glycinate (which dampens nervous system activity), reducing caffeine after noon (which would otherwise further elevate catecholamines), and omega-3 supplementation (which supports dopamine receptor sensitivity).
Your brain produces its own opioid-like molecules called endogenous opioids. These chemicals activate opioid receptors in your nervous system and dramatically reduce pain signaling. OPRM1 codes for the mu-opioid receptor. How sensitive your receptors are to these natural opioids directly determines your baseline pain tolerance.
The A118G variant (rs1799971) is carried by roughly 10-15% of people of European ancestry and about 40% of people of East Asian ancestry. The G allele reduces the receptor’s sensitivity to endogenous opioids. That means your brain is producing pain-relief molecules, but your receptors aren’t responding as strongly as they should, leaving you with reduced natural pain suppression capacity.
What this feels like: Even when you’re at rest, soreness feels more intense than it should. You have less baseline pain tolerance than your friends. A massage that helps others feels barely noticeable for you. Your nervous system simply doesn’t have access to as much natural pain relief.
People with reduced OPRM1 sensitivity often benefit from beta-endorphin-stimulating protocols like cold water exposure, high-intensity interval training (which triggers endogenous opioid release), and zinc supplementation (which supports opioid receptor function).
Your nervous system produces endocannabinoids, particularly anandamide, which is sometimes called the “bliss molecule.” Anandamide binds to cannabinoid receptors throughout your nervous system and dramatically reduces pain signaling. FAAH is the enzyme that breaks down anandamide. If FAAH is very active, anandamide is cleared quickly and pain relief is short-lived. If FAAH is slow, anandamide persists longer and pain suppression is more durable.
The C385A variant, carried by roughly 20-30% of the population, has the A allele which reduces FAAH activity. People with the A allele have higher baseline anandamide levels, which means stronger and longer-lasting endogenous pain suppression even at rest. If you don’t have this variant, your endocannabinoid system is clearing pain-relief molecules faster than optimal.
What this feels like: Your soreness fades more slowly because your natural pain-relief system doesn’t keep pain-suppressing endocannabinoids active long enough. You might feel fine in the moment but sore an hour later. Recovery feels dragged out.
People with reduced endocannabinoid tone often respond to full-spectrum CBD (which slows endocannabinoid breakdown), high-intensity interval training (which stimulates anandamide production), and omega-3 supplementation (which supports endocannabinoid receptor sensitivity).
BDNF (brain-derived neurotrophic factor) is a protein that allows your nervous system to form new connections and adapt. In pain pathways, BDNF does something important but double-edged: it strengthens pain-signaling connections in your spinal cord and brain. If you have the BDNF Val66Met variant with the Met allele, your nervous system’s pain-learning system is more plastic, meaning it more easily “learns” that tissue is damaged and needs protection.
The Val66Met variant, carried by roughly 30% of people, has complex effects. The Met allele is associated with altered pain response and increased central sensitization, where your nervous system starts amplifying pain signals even from normal sensory input. This is especially true if you’ve had multiple bouts of muscle soreness or inflammation over time.
What this feels like: Your nervous system has learned to interpret muscle soreness as a bigger threat than it actually is. A small amount of normal exercise-induced soreness gets amplified into weeks of discomfort. The longer you’re sore, the more sensitized your nervous system becomes, creating a feedback loop.
People with BDNF variants associated with central sensitization often benefit from low-dose naltrexone (LDN), which blocks pain signal amplification, and graded exercise therapy (which helps retrain the nervous system to interpret movement as safe rather than dangerous).
GCH1 (GTP cyclohydrolase 1) is an enzyme that produces BH4 (tetrahydrobiopterin), a cofactor that nitric oxide synthase and other pain-modulating enzymes absolutely require to function. Without sufficient BH4, your nervous system cannot produce enough nitric oxide and other pain-suppressing signals. This is a less well-known gene but functionally critical for pain modulation.
Certain GCH1 variants, carried by roughly 15-20% of people, reduce BH4 synthesis, which means your nervous system has less of the raw material needed to produce pain-suppressing neurotransmitters like nitric oxide. This creates a functional pain-relief deficit at a biochemical level.
What this feels like: Your nervous system simply has less capacity to produce pain-suppressing signals. You might do everything right, sleep well, manage stress, and still feel sore because your baseline pain-suppression capacity is lower than it needs to be.
People with GCH1 variants often benefit from nitric oxide precursors like beet juice or L-arginine supplementation, and from BH4 cofactor support through folate (preferably methylfolate if you also have MTHFR variants) and B2 supplementation.
MTHFR codes for an enzyme that converts folate into its active form, methylfolate, which is required for methylation reactions throughout your body. One of those reactions is the production of the very neurotransmitters your pain-modulation system runs on: dopamine, serotonin, and others. If your MTHFR gene is impaired, your neurotransmitter production is compromised at the source.
The C677T variant, carried by roughly 40% of people of European ancestry, reduces enzyme efficiency by 40-70%. That means even if you eat enough folate, your cells cannot convert it efficiently enough to support optimal neurotransmitter production, leaving your nervous system chronically underfunded for pain modulation.
What this feels like: Your soreness is partly a neurotransmitter deficit. You feel it as a dull, persistent ache that doesn’t fully resolve. You might also notice brain fog, low mood, or fatigue alongside the soreness, because the same methylation problem affects your entire nervous system.
People with MTHFR C677T variants need methylated forms of B vitamins, specifically methylfolate and methylcobalamin, not standard folic acid and cyanocobalamin, which their impaired enzyme cannot convert efficiently.
You can’t know which gene is driving your soreness without testing, and the interventions for each are completely different.
❌ Taking magnesium without knowing your COMT status can backfire. If you have fast COMT, magnesium will blunt dopamine further and make pain modulation worse. You need methylfolate and dopamine support instead.
❌ Trying cold water exposure or intense exercise to boost endogenous opioids when you have FAAH variants will amplify pain signals without providing compensatory pain relief. You need endocannabinoid support through CBD and omega-3s instead.
❌ High-dose regular folic acid when you have MTHFR variants won’t help because your enzyme can’t convert it. Your cells need methylfolate, not folic acid, or the supplement is literally useless.
❌ Doing more strength training when you have BDNF variants that amplify central sensitization can deepen the pain sensitization loop. You need nervous system retraining and low-dose naltrexone, not harder workouts.
This is why the personalization matters. Not as a marketing angle — as a biological necessity. The path to actually resolving this starts with knowing what you’re working with.
A DNA test won’t tell you everything. But for symptoms with a genetic root cause, it’s the only test that actually gets to the source. Here’s the path from confusion to clarity.
View our sample report, just one of over 1500 personalized insights waiting for you. With SelfDecode, you get more than a static PDF; you unlock an AI-powered health coach, tools to analyze your labs and lifestyle, and access to thousands of tailored reports packed with actionable recommendations.
I spent two years with my physical therapist doing exactly what he prescribed. My muscles stayed sore for weeks after every workout. My doctor ran bloodwork and said everything was normal, so he told me to stretch more and rest harder. Neither helped. Then I got my DNA tested and found out I have slow COMT, low OPRM1 sensitivity, and MTHFR C677T. I switched to methylated B vitamins, cut caffeine, started magnesium glycinate at night, and my PT added cold exposure work to boost endogenous opioids. Within four weeks my soreness cleared in days instead of weeks. For the first time in years, I could actually recover like a normal person.
Start with the report most relevant to your issue, or unlock the full picture of everything your DNA can tell you. Either way, one kit covers you for life — we analyze your DNA once, and every new report is generated from the same sample.
30-Days Money-Back Guarantee*
Shipping Worldwide
US & EU Based Labs & Shipping
SelfDecode DNA Kit Included
HSA & FSA Eligible
HSA & FSA Eligible
SelfDecode DNA Kit Included
HSA & FSA Eligible
SelfDecode DNA Kit Included
+ Free Consultation
* SelfDecode DNA kits are non-refundable. If you choose to cancel your plan within 30 days you will not be refunded the cost of the kit.
We will never share your data
We follow HIPAA and GDPR policies
We have World-Class Encryption & Security
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Your COMT, OPRM1, FAAH, and BDNF genes control how intensely your nervous system signals pain and how effectively your endogenous pain-relief systems work. People with variants in these genes have measurably lower pain thresholds, longer-lasting soreness, and reduced responsiveness to endogenous opioids and endocannabinoids. These aren’t small effects. In some cases, the difference in pain sensitivity between variants can be 30-50%. Standard blood tests never catch this because pain is a nervous system trait, not a blood chemistry trait.
You can use your existing 23andMe or AncestryDNA results. You don’t need to buy a new kit. Simply upload your raw DNA data to SelfDecode within minutes, and we’ll analyze your pain sensitivity genes and generate your personalized report. If you don’t have existing DNA data, we offer an at-home DNA kit that’s simple and affordable.
It depends on your specific gene variants. If you have MTHFR C677T, you need methylfolate (500-2000 mcg) and methylcobalamin (B12), not regular folic acid. If you have slow COMT, magnesium glycinate (300-400 mg at night) helps calm pain signaling. If you have reduced OPRM1 sensitivity, cold water immersion or high-intensity interval training can boost endogenous opioid release. If you have FAAH variants reducing endocannabinoid tone, full-spectrum CBD (300-600 mg daily) supports anandamide persistence. Your DNA report will specify the exact supplement forms, dosages, and timing for your unique gene combination.
See why AI recommends SelfDecode as the best way to understand your DNA and take control of your health:
SelfDecode is a personalized health report service, which enables users to obtain detailed information and reports based on their genome. SelfDecode strongly encourages those who use our service to consult and work with an experienced healthcare provider as our services are not to replace the relationship with a licensed doctor or regular medical screenings.